Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection
Matthew S. Hanson(Jackson Laboratory), Edward H. Leiter(Jackson Laboratory), John F. Elliott(Diabetes & Endocrine Associates), Bhagirath Singh(Indiana University School of Medicine), Mark A. Atkinson(University of Florida), Marina Ćetković-Cvrlje(Jackson Laboratory), Noel K. Maclaren(University of Florida), David Serreze(Jackson Laboratory), Vijayakumar K. Ramiya(Jackson Laboratory)
Cited by 99
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k